Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cathy M Helgason

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Pharmacogenomics|November 24, 2007
Factors influencing warfarin dose requirements in African-AmericansKathryn M Momary, Nancy L Shapiro, Marlos Ag Viana, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 25, 2009
Influence of cyclooxygenase-1 genotype on ex vivo aspirin response in patients at risk for strokeKathryn M Momary, Nancy L Shapiro, Larry D Brace, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Pharmacogenomics|November 24, 2007
Factors influencing warfarin dose requirements in African-AmericansKathryn M Momary, Nancy L Shapiro, Marlos Ag Viana, et al.
Cerebrovascular Diseases (Basel, Switzerland)|April 25, 2009
Influence of cyclooxygenase-1 genotype on ex vivo aspirin response in patients at risk for strokeKathryn M Momary, Nancy L Shapiro, Larry D Brace, et al.
Pageof 3